SR
Syntax Research’s CRISPR Therapeutics CRSP Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $12.2K | Hold |
250
| – | – | 0.01% | 131 |
|
2025
Q1 | $8.51K | Hold |
250
| – | – | 0.01% | 143 |
|
2024
Q4 | $9.84K | Hold |
250
| – | – | 0.01% | 147 |
|
2024
Q3 | $11.7K | Hold |
250
| – | – | 0.01% | 143 |
|
2024
Q2 | $13.5K | Hold |
250
| – | – | 0.01% | 123 |
|
2024
Q1 | $17K | Hold |
250
| – | – | 0.01% | 123 |
|
2023
Q4 | $15.7K | Hold |
250
| – | – | 0.01% | 123 |
|
2023
Q3 | $11.3K | Buy |
+250
| New | +$11.3K | 0.01% | 134 |
|